Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
January 31, 2024
In this blog, we outline findings from a new paper that explores the barriers to deeper cross-provider cooperation for development and how such challenges can be overcome. Ultimately, we show that cooperation between providers is limited by differences in their visions and principles for cooperation...
POLICY PAPERS
January 31, 2024
Despite the increasing imperative for cross-provider collaboration, the quest for a truly “global” development paradigm remains elusive, marked by persistent divides between different types of development providers’ normative frameworks, models, experiences, capacities, and institutional allegiances...
POLICY PAPERS
January 31, 2024
At a time when progress towards the 2030 Agenda has stalled, there is a clear need for collective—and cooperative—development action to put the agenda back on track. The good news is that the number of countries with institutions dedicated to sharing knowledge, skills, and resources to support devel...
Blog Post
January 31, 2024
Starting from the understanding that cooperative action remains critical to sourcing the resources, skills, and knowledge needed to advance the common Sustainable Development Goals (SDGs), this four-part series focuses on the challenges and opportunities for deepening cross-provider cooperation for ...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
POLICY PAPERS
January 30, 2024
For nearly 25 years, Gavi has delivered impact and value for money and remained one of the most successful global health initiatives. Gavi’s success has been driven by its use of three primary levers: (1) accelerating new vaccine introductions, (2) increasing equitable immunization coverage, and (3)...